Rakovina Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Jul '25 Jul 25, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Market Capitalization	14	27	6	13	15	-	Upgrade
Market Cap Growth	90.84%	348.09%	-52.61%	-18.16%	-	-	Upgrade
Enterprise Value	15	28	6	11	12	-	Upgrade
Last Close Price	0.67	1.90	0.85	1.80	2.20	-	Upgrade
PB Ratio	5.92	6.21	1.63	2.09	1.80	-	Upgrade
P/TBV Ratio	-	83.04	-	13.06	5.19	-	Upgrade
Debt / Equity Ratio	0.58	0.33	0.36	-	-	-	Upgrade
Quick Ratio	0.06	0.72	2.95	8.52	25.32	0.40	Upgrade
Current Ratio	0.39	1.17	4.09	9.99	26.94	0.40	Upgrade
Return on Equity (ROE)	-206.27%	-102.34%	-54.02%	-38.35%	-129.24%	-	Upgrade
Return on Assets (ROA)	-69.36%	-41.58%	-27.53%	-23.83%	-35.72%	-33.00%	Upgrade
Return on Capital (ROIC)	-80.64%	-44.21%	-28.19%	-24.19%	-36.20%	-	Upgrade
Earnings Yield	-38.82%	-15.26%	-43.86%	-22.21%	-35.95%	-	Upgrade
Buyback Yield / Dilution	-43.35%	-18.18%	-0.03%	-30.22%	-	-	Upgrade

Updated Nov 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.